Vanguard Global Advisers’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.22M Sell
85,831
-1,808
-2% -$39.1K ﹤0.01% 1183
2026
Q2
$1.77M Buy
87,639
+37,476
+75% +$756K ﹤0.01% 1349
2026
Q1
$983K Buy
+50,163
New +$1.23M ﹤0.01% 1665

Other funds holding AMPH

Vanguard Global Advisers's AMPH Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Amphastar Pharmaceuticals (AMPH) stake by 2.1% in Q3 2026, selling an estimated $39.1K and leaving 85,831 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Vanguard Global Advisers first reported a position in AMPH in Q1 2026 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Vanguard Global Advisers held 85,831 shares of Amphastar Pharmaceuticals worth $2.22M as of Q3 2026.
  • Vanguard Global Advisers sold 1,808 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $39.1K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1183 holding.
  • Vanguard Global Advisers first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.